Trial Profile
A Confirmatory Trial of SK-PC-B70M in Mild to Moderate Alzheimer's Disease.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs SK-PC-B70M (Primary) ; Donepezil
- Indications Alzheimer's disease
- Focus Therapeutic Use
- Sponsors SK Chemicals
- 07 Dec 2010 New trial record